Current Opinion in Nephrology and Hypertension
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 72.4% | 0.939 | Q1 | 82.1% |
| 2024 | 2.4 | Q2 | 62.7% | 0.982 | Q1 | 83.8% |
| 2023 | 2.2 | Q2 | 57.9% | 0.959 | Q1 | 84.5% |
| 2022 | 3.2 | Q2 | 76.8% | 0.901 | Q1 | 83.8% |
| 2021 | 3.4 | Q2 | 73.1% | 0.968 | Q1 | 85.9% |
| 2020 | — | — | 1.158 | Q1 | 88.3% | |
| 2019 | — | — | 1.091 | Q1 | 87.5% | |
| 2018 | — | — | 1.381 | Q1 | 90.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1062-4821
ISSN
1473-6543
country
UScoverage
1992-2026